0000950170-23-064833.txt : 20231117
0000950170-23-064833.hdr.sgml : 20231117
20231117162211
ACCESSION NUMBER: 0000950170-23-064833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231115
FILED AS OF DATE: 20231117
DATE AS OF CHANGE: 20231117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIINBERG ULF
CENTRAL INDEX KEY: 0001187314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 231419023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
ownership.xml
4
X0508
4
2023-11-15
0001098972
AGENUS INC
AGEN
0001187314
WIINBERG ULF
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
true
false
false
false
false
Common Stock
2023-11-15
4
P
false
25000
0.76
A
124063
D
Represents open market purchase of common stock for cash.
/s/Christine Klaskin, as Attorney-in-Fact for Ulf Wiinberg
2023-11-17